Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID

被引：2

作者：

Baig, Abdul Mannan ^{[1
]}

Greig, Nigel H. ^{[2
]}

Gerlach, Joachim ^{[3
]}

Salunke, Prakash ^{[4
]}

Fabrowski, Mark ^{[5
]}

Viduto, Valentina ^{[6
]}

Ali, Tazeen ^{[1
]}

机构：

[1] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi 74800, Pakistan

[2] Natl Inst Aging, Baltimore, MD 21224 USA

[3] Hlth Shield, Vedicinals-9, D-40764 Langenfeld, Germany

[4] German-Indian Biotech Vedicinals-9,, Talawade 412114, India

[5] Univ Hosp Sussex, Royal Sussex County Hosp, Dept Emergency Med, Brighton BN2 5BE, East Sussex, England

[6] Long COVID Fdn, Leeds LS25 1NB, W Yorkshire, England

来源：

ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 20期

关键词：

COVID-19; Long-COVID; Treatment Long-COVID; Post-COVID-19; sequelae; Neurological Deficits; Neuro-COVID;

D O I：

10.1021/acschemneuro.2c00482

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

With reports of diverse neurological deficits in the acute phase of COVID-19, there is a surge in neurological findings in Long-COVID-a protracted phase of SARS-CoV-2 infection. Very little is known regarding the pathogenic mechanisms of Neuro-COVID in the above two settings in the current pandemic. Herein, we hint toward the possible molecular mechanism that can contribute to the signs and symptoms of patients with neurological deficits and possible treatment and prevention modalities in the acute and chronic phases of COVID-19.

引用

页码：2934 / 2938

页数：5

共 50 条

[21] Initial COVID-19 Severity and Long-COVID Manifestations: An Observational Analysis
Goel, Nitin
Goyal, Nitesh
Spalgais, Sonam
Mrigpuri, Parul
Varma-Basil, Mandira
Khanna, Madhu
Nagaraja, Ravishankar
Menon, Balakrishnan
Kumar, Raj
THORACIC RESEARCH AND PRACTICE, 2023, 24 (01) : 22 - 28
[22] Neurological Complications of COVID-19: Underlying Mechanisms and Management
Shehata, Ghaydaa A.
Lord, Kevin C.
Grudzinski, Michaela C.
Elsayed, Mohamed
Abdelnaby, Ramy
Elshabrawy, Hatem A.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
[23] Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review
Fernandez-de-las-Penas, Cesar
Torres-Macho, Juan
Catahay, Jesus Alfonso
Macasaet, Raymart
Velasco, Jacqueline Veronica
Macapagal, Sharina
Caldararo, Mario
Henry, Brandon Michael
Lippi, Giuseppe
Franco-Moreno, Ana
Notarte, Kin Israel
INFECTION, 2024, 52 (01) : 43 - 58
[24] Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review
César Fernández-de-las-Peñas
Juan Torres-Macho
Jesus Alfonso Catahay
Raymart Macasaet
Jacqueline Veronica Velasco
Sharina Macapagal
Mario Caldararo
Brandon Michael Henry
Giuseppe Lippi
Ana Franco-Moreno
Kin Israel Notarte
Infection, 2024, 52 : 43 - 58
[25] From COVID-19 to long COVID; the forms of the neurological manifestations
Ahuja, Sana
Zaheer, Sufian
JOURNAL OF MIND AND MEDICAL SCIENCES, 2023, 10 (02): : 209 - 216
[26] COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics
Violi, Francesco
Harenberg, Job
Pignatelli, Pasquale
Cammisotto, Vittoria
THROMBOSIS AND HAEMOSTASIS, 2024, 124 (03) : 274 - 276
[27] Determination of COVID-19 Late Disorders as Possible Long-COVID and/or Vaccination Consequences
Larijani, Mona Sadat
Bavand, Anahita
Banifazl, Mohammad
Ashrafian, Fatemeh
Moradi, Ladan
Ramezani, Amitis
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2024, 15
[28] Long-COVID and comorbid depression and anxiety two years into the COVID-19 pandemic*,**,***
Rudenstine, Sasha
Schulder, Talia
Bhatt, Krish J.
McNeal, Kat
Ettman, Catherine K.
Galea, Sandro
PSYCHIATRY RESEARCH, 2022, 317
[29] Long-COVID?Long COVID?
Reinhold Kerbl
Monatsschrift Kinderheilkunde, 2022, 170 (6) : 490 - 492
[30] Pneumomediastinum in COVID-19: Assessment of Treatment Modalities
Uts, A.
Azzopardi, S.
Megally, M.
Coletta, F.
Saffran, L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209

← 1 2 3 4 5 →